FDA Approves Inflectra as 'Biosimilar' to Remicade

Share this content:
FDA Approves Inflectra as 'Biosimilar' to Remicade
FDA Approves Inflectra as 'Biosimilar' to Remicade

WEDNESDAY, April 6, 2016 (HealthDay News) -- The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug, Inflectra, for adults with Crohn's disease, rheumatoid arthritis, or chronic plaque psoriasis, among other prescribed uses.

In a media release, the agency said Inflectra was biosimilar to Janssen Biotech's Remicade (infliximab), first licensed in 1998.

A biosimilar drug is sanctioned based on its maker's ability to show that it is "highly similar" to an already-approved biological drug that is generally derived from a living organism, such as a person, animal, microorganism, or yeast, the FDA said. The maker of a biosimilar drug also must prove that the product has no "clinically meaningful difference" in safety and effectiveness from the original drug, and that the newer product has only "minor differences in clinically inactive components" from the original.

Inflectra's most common clinical side effects included respiratory infection, headache, cough, and stomach pain. Infusion reactions (including fever, chills, chest pain, low blood pressure or high blood pressure, shortness of breath, rash, and itching) can occur within two hours of infusion, the FDA said. In addition, Inflectra's label will include a boxed warning that the drug could increase risk of serious infections leading to hospitalization or death, such as tuberculosis, sepsis, and invasive fungal infections. The warning also says lymphoma and other malignancies, some fatal, have been reported in children and teens who used infliximab or similar drugs.

Inflectra is produced by the Korean drug manufacturer Celltrion for Lake Forest, Ill.-based Hospira.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Dermatography Helps Lessen Appearance of Surgical Scars

Dermatography Helps Lessen Appearance of Surgical Scars

Pigments can restore more natural skin appearance that patients are happy with

Drug-Resistant Bacteria Live in America's Water Systems

Drug-Resistant Bacteria Live in America's Water Systems

Bacteria found in plumbing may sicken thousands each year

Deep Brain Stimulation May Improve TBI Symptoms

Deep Brain Stimulation May Improve TBI Symptoms

Deep brain stimulation appears to boost function and quality of life

is free, fast, and customized just for you!

Already a member?

Sign In Now »